![](/img/cover-not-exists.png)
A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy
Richard F Kefford, Philip R Clingan, Benjamin Brady, Andrea Ballmer, Adele Morganti, Peter HerseyVolume:
9
Language:
english
DOI:
10.1186/1476-4598-9-69
Date:
December, 2010
File:
PDF, 705 KB
english, 2010